Relapsing multiple sclerosis Trials in Rosario, Argentina
Conditions / Relapsing multiple sclerosis / Rosario, Argentina
Relapsing multiple sclerosis has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03650114 | Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02792218 | Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT04338022 | Study of Evobrutinib in Participants With RMS (evolutionRMS 1) | TERMINATED | PHASE3 |
| NCT04353492 | An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab | COMPLETED | PHASE3 |
| NCT04410991 | Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) | COMPLETED | PHASE3 |
| NCT05156281 | Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04586010 | A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06372145 | A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05147220 | Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01247324 | A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 |